Disclosure submitted to the exchange on April 2, 2025 and exchange email dated April 11, 2025
JBCHEPHARM · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
JB Chemicals & Pharmaceuticals has re-submitted a disclosure originally filed on April 2, 2025, after the original filing did not appear on the BSE website due to a wrong script code (106943 instead of 506943). The original disclosure related to a cautionary letter received from BSE and NSE on March 28, 2025, the contents of which were noted by the company's Board of Directors on April 2, 2025. The company has now re-filed the disclosure under the correct script code as advised by the exchange. The actual content or reason behind the cautionary letter has not been detailed in this filing.
This is primarily a procedural re-submission, so the immediate stock impact is likely minimal. However, investors should watch for any further details on the cautionary letter from the exchanges, as such letters are often issued in connection with unusual price/volume movements or pending corporate actions that may warrant caution.